Rejected after two major revisions.

(0) 讚！ | 深渊半梅

Another major overhaul has been given, and it has been repaired now. We are waiting for the results.

(0) 讚！ | 深渊半梅

It has been half a month since Da Xiu Xiu returned, and currently in a state of decision, not sure about the situation.

(0) 讚！ | 深渊半梅

Can only see the review status, cannot see the reviewers.

(0) 讚！ | 花拳卫杰

You can view the review status and see the changes in the status of the manuscript every time it is received.

(0) 讚！ | Adelaide Lawson

Can you check the review status and see how many people have been invited to review these issues?

(0) 讚！ | Caroline Lucas

Review speed: 2.0 | Submission hit rate: 75.0
Experience sharing: 1

(0) 讚！ | 伏魔凯歌

Review speed: 1.0 | Submission acceptance rate: 25.0 Emphasis on research topics: Organ transplant experience sharing: Approximately one month per round of review. One major revision was made

(0) 讚！ | 百花莹莹

How long does it take to publish?

(0) 讚！ | 暗月寺丹红

Can we accept it directly after the renovation is completed?

(0) 讚！ | 百花莹莹

My decision on 11-21 is still in process and I haven't received any confirmation yet

(0) 讚！ | 百花莹莹

Review speed: 2.0 | Submission hit rate: 50.0 Main research direction: organ transplantation; Transplantation experience sharing: Submitted on June 28, 2022, reviewed by two experts during the process, major revisions, requested extension of 1 month for additional experiments, accepted on December 7, 2022. Editor is very good, replies to emails very promptly (usually on the same day when working), borrowing from the advisor's words: reputable old journal

(0) 讚！ | 宗室芳蔼

It's very good that the magazine is quick in reviewing and approving external opinions

(0) 讚！ | 宗室芳蔼

Review Speed: 1.0
Focus on Research Area: Organ Transplantation Experience Sharing
Submitted on November 1, 2022, Decision in process, it's been almost 5 working days, anxiously waiting

(0) 讚！ | 珉林歌飞

Review Speed: 6.0 | Submission Hit Rate: 50.0
Emphasized Research Direction: Transplant Experience Sharing
Submitted on 28th June, 2022, reviewed by two experts during the process. Major revisions were required, additional experiments were requested and an extension of one month was granted. Accepted on 7th December, 2022. The editor was very good, replied to emails very promptly (usually on the same day). In the words of my supervisor: a prestigious journal, reliable

(0) 讚！ | 宗室芳蔼

How many days for review? I have been under review for over a month

(0) 讚！ | 百花莹莹

I refused

(0) 讚！ | Martina Jeremy

Decision in Process

(0) 讚！ | Martina Jeremy

Decision in process. How will the results be one week later?

(0) 讚！ | Walter Marcellus

Heavy research focus: Transplantation; sharing liver transplantation experience: submitted on 6-21, not sure how it turned out

(0) 讚！ | Martina Jeremy

Main Research Focus: Sharing experiences in transplantation. Please advise: Submitted on 6/28, status shows "Submissions Being Processed." Received confirmation email with manuscript number on 6/29. Status has been showing "Similarity Check/iThenticate Results (29%)" since then. Should I revise and resubmit for plagiarism reduction? Or should I wait for the editor's response? Thank you

(0) 讚！ | 宗室芳蔼

It was accepted within half a day, the efficiency speed of Americans is quite different from that of European grandfathers, really

(0) 讚！ | 雾都景同

Do we need to select "yes" for open access? Do we need to upload a form if we choose "yes"? I have never encountered this in other journals

(0) 讚！ | 岭南佩杉

Medical Subject Headings (MeSH) is a metadata system published by the United States National Library of Medicine, widely used for medical information retrieval. It is used in the field of life sciences for indexing journal articles and books. The main purpose of MeSH is to classify the vast amount of literature in PubMed/MEDLINE

(0) 讚！ | 维尔娜菲茨杰拉德

In the field of medicine, most journals and clinical papers particularly recommend the use of MeSH. Using MeSH terms is to help with literature searches and increase the weight of publications

(0) 讚！ | 维尔娜菲茨杰拉德